Sarepta Therapeutics Stock Price on November 7, 2024
| SRPT Stock | USD 126.70 2.30 1.78% |
Below is the normalized historical share price chart for Sarepta Therapeutics extending back to June 04, 1997. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sarepta Therapeutics stands at 126.70, as last reported on the 11th of December 2024, with the highest price reaching 129.37 and the lowest price hitting 126.00 during the day.
If you're considering investing in Sarepta Stock, it is important to understand the factors that can impact its price. Currently, Sarepta Therapeutics is very steady. Sarepta Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0193, which indicates the firm had a 0.0193% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Sarepta Therapeutics, which you can use to evaluate the volatility of the company. Please validate Sarepta Therapeutics' Risk Adjusted Performance of 0.0134, semi deviation of 2.16, and Coefficient Of Variation of 11938.54 to confirm if the risk estimate we provide is consistent with the expected return of 0.0524%.
At this time, Sarepta Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 97 M in 2024, whereas Capital Stock is likely to drop 9,167 in 2024. . Price Earnings To Growth Ratio is likely to gain to 0.63 in 2024, whereas Price To Sales Ratio is likely to drop 6.81 in 2024. Sarepta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of June 1997 | 200 Day MA 129.9507 | 50 Day MA 122.4426 | Beta 0.803 |
Sarepta |
Sharpe Ratio = 0.0193
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | SRPT | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.72 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Sarepta Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sarepta Therapeutics by adding it to a well-diversified portfolio.
Price Book 10.0262 | Enterprise Value Ebitda 66.4658 | Price Sales 7.5118 | Shares Float 91.2 M | Wall Street Target Price 183.5964 |
Sarepta Therapeutics Main Headline on 7th of November 2024
Sarepta upgraded at Cantor on pipeline, growth potential by seekingalpha.com
Cantor Fitzgerald upgrades Sarepta Therapeutics to overweight, citing strong growth potential and positive Q3 results. Read more here.
Sarepta Therapeutics Valuation on November 7, 2024
It is possible to determine the worth of Sarepta Therapeutics on a given historical date. On November 7, 2024 Sarepta was worth 132.4 at the beginning of the trading date compared to the closed value of 120.42. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sarepta Therapeutics stock. Still, in general, we apply an absolute valuation method to find Sarepta Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sarepta Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sarepta Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 126.50 | 128.32 | 122.45 | 127.97 | 1,453,610 | |
11/07/2024 | 132.40 | 133.00 | 117.52 | 120.42 | 2,393,179 |
| 120.50 | 121.96 | 116.32 | 121.61 | 1,483,804 |
| Backtest Sarepta Therapeutics | | | Sarepta Therapeutics History | | | Sarepta Therapeutics Valuation | Previous | Next |
Sarepta Therapeutics Trading Date Momentum on November 7, 2024
| On November 08 2024 Sarepta Therapeutics was traded for 121.61 at the closing time. The top price for the day was 121.96 and the lowest listed price was 116.32 . The trading volume for the day was 1.5 M. The trading history from November 8, 2024 was a factor to the next trading day price appreciation. The trading price change against the next closing price was 0.99% . The trading price change against the current closing price is 14.57% . |
Sarepta Therapeutics Fundamentals Correlations and Trends
By evaluating Sarepta Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sarepta Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sarepta financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sarepta Therapeutics Stock history
Sarepta Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sarepta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sarepta Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sarepta Therapeutics stock prices may prove useful in developing a viable investing in Sarepta Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 92.4 M | 97 M | |
| Net Loss | -633.1 M | -601.5 M |
Sarepta Therapeutics Quarterly Net Working Capital |
|
Sarepta Therapeutics Stock Technical Analysis
Sarepta Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sarepta Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Sarepta Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sarepta Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Sarepta Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sarepta Therapeutics shares will generate the highest return on investment. By undertsting and applying Sarepta Therapeutics stock market strength indicators, traders can identify Sarepta Therapeutics entry and exit signals to maximize returns
Sarepta Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sarepta Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Sarepta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sarepta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0134 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | 0.0151 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Sarepta Stock Analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.